AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
Pharmacokinetic parameters of protease inhibitors and the Cmin/IC50 ratio:Call for consensus
Authors: Becker, S Fisher, A Flexner, C Gerber, JG Haubrich, R Kashuba, ADM Luber, AD Piscitelli, SC
Citation: S. Becker et al., Pharmacokinetic parameters of protease inhibitors and the Cmin/IC50 ratio:Call for consensus, J ACQ IMM D, 27(2), 2001, pp. 210-211
Antifungal pharmacodynamics: Concentration-effect relationships in vitro and in vivo
Authors: Groll, AH Piscitelli, SC Walsh, TJ
Citation: Ah. Groll et al., Antifungal pharmacodynamics: Concentration-effect relationships in vitro and in vivo, PHARMACOTHE, 21(8), 2001, pp. 133S-148S
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis
Authors: Petraitis, V Petraitiene, R Groll, AH Sein, T Schaufele, RL Lyman, CA Francesconi, A Bacher, J Piscitelli, SC Walsh, TJ
Citation: V. Petraitis et al., Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis, ANTIM AG CH, 45(2), 2001, pp. 471-479
Compartmental pharmacokinetics of the antifungal echinocandin caspofungin (MK-0991) in rabbits
Authors: Groll, AH Gullick, BM Petraitiene, R Petraitis, V Candelario, M Piscitelli, SC Walsh, TJ
Citation: Ah. Groll et al., Compartmental pharmacokinetics of the antifungal echinocandin caspofungin (MK-0991) in rabbits, ANTIM AG CH, 45(2), 2001, pp. 596-600
Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits
Authors: Groll, AH Mickiene, D Petraitis, V Petraitiene, R Ibrahim, KH Piscitelli, SC Bekersky, I Walsh, TJ
Citation: Ah. Groll et al., Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits, ANTIM AG CH, 45(12), 2001, pp. 3322-3327
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): Reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling
Authors: Groll, AH Mickiene, D Petraitiene, R Petraitis, V Lyman, CA Bacher, JS Piscitelli, SC Walsh, TJ
Citation: Ah. Groll et al., Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): Reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling, ANTIM AG CH, 45(10), 2001, pp. 2845-2855
Drug therapy: Interactions among drugs for HIV and opportunistic infections
Authors: Piscitelli, SC Gallicano, KD
Citation: Sc. Piscitelli et Kd. Gallicano, Drug therapy: Interactions among drugs for HIV and opportunistic infections, N ENG J MED, 344(13), 2001, pp. 984-996
Drug-drug interactions in human immunodeficiency virus infection
Authors: Flexner, CW Piscitelli, SC
Citation: Cw. Flexner et Sc. Piscitelli, Drug-drug interactions in human immunodeficiency virus infection, ANTIRETROVIRAL THERAPY, 2001, pp. 339-350
Herpes zoster in an HIV-negative man on ritonavir
Authors: Miller, KD Piscitelli, SC Davey, RT
Citation: Kd. Miller et al., Herpes zoster in an HIV-negative man on ritonavir, AIDS PAT CA, 14(10), 2000, pp. 527-528
Update on preventing vertical transmission of HIV type 1
Authors: Chen, F Pau, AK Piscitelli, SC
Citation: F. Chen et al., Update on preventing vertical transmission of HIV type 1, AM J HEAL S, 57(17), 2000, pp. 1616-1623
An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons
Authors: Kaplan, JE Masur, H Holmes, KK Freedberg, KA Holtgrave, D Piscitelli, SC Van Dyke, R Watts, H
Citation: Je. Kaplan et al., An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons, CLIN INF D, 30, 2000, pp. S15-S28
The effect of ritonavir on the pharmacokinetics of meperidine and normeperidine
Authors: Piscitelli, SC Kress, DR Bertz, RJ Pau, A Davey, R
Citation: Sc. Piscitelli et al., The effect of ritonavir on the pharmacokinetics of meperidine and normeperidine, PHARMACOTHE, 20(5), 2000, pp. 549-553
Indinavir concentrations and St John's wort
Authors: Piscitelli, SC Burstein, AH Chaitt, D Alfaro, RM Falloon, J
Citation: Sc. Piscitelli et al., Indinavir concentrations and St John's wort, LANCET, 355(9203), 2000, pp. 547-548
A risk-benefit assessment of interleukin-2 as an adjunct to antiviral therapy in HIV infection
Authors: Piscitelli, SC Bhat, N Pau, A
Citation: Sc. Piscitelli et al., A risk-benefit assessment of interleukin-2 as an adjunct to antiviral therapy in HIV infection, DRUG SAFETY, 22(1), 2000, pp. 19-31
Effects of fluconazole and clarithromycin on rifabutin and 25-O-desacetylrifabutin pharmacokinetics
Authors: Jordan, MK Polis, MA Kelly, G Narang, PK Masur, H Piscitelli, SC
Citation: Mk. Jordan et al., Effects of fluconazole and clarithromycin on rifabutin and 25-O-desacetylrifabutin pharmacokinetics, ANTIM AG CH, 44(8), 2000, pp. 2170-2172
Compartmental pharmacokinetics and tissue distribution of multilamellar liposomal nystatin in rabbits
Authors: Groll, AH Mickiene, D Werner, K Petraitiene, R Petraitis, V Calendario, M Field-Ridley, A Crisp, J Piscitelli, SC Walsh, TJ
Citation: Ah. Groll et al., Compartmental pharmacokinetics and tissue distribution of multilamellar liposomal nystatin in rabbits, ANTIM AG CH, 44(4), 2000, pp. 950-957
Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbits
Authors: Groll, AH Mickiene, D Piscitelli, SC Walsh, TJ
Citation: Ah. Groll et al., Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbits, ANTIM AG CH, 44(2), 2000, pp. 408-410
Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system
Authors: Groll, AH Giri, N Petraitis, V Petraitiene, R Candelario, M Bacher, JS Piscitelli, SC Walsh, TJ
Citation: Ah. Groll et al., Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system, J INFEC DIS, 182(1), 2000, pp. 274-282
Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers
Authors: Burstein, AH Horton, RL Dunn, T Alfaro, RM Piscitelli, SC Theodore, W
Citation: Ah. Burstein et al., Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers, CLIN PHARM, 68(6), 2000, pp. 605-612
Drug interactions with antiretrovirals for HIV infection
Authors: Piscitelli, SC Struble, KA
Citation: Sc. Piscitelli et Ka. Struble, Drug interactions with antiretrovirals for HIV infection, INFEC DIS S, 2000, pp. 39-60
High-performance liquid chromatographic determination of liposomal nystatin in plasma and tissues for pharmacokinetic and tissue distribution studies
Authors: Groll, AH Mickiene, D Werner, K Piscitelli, SC Walsh, TJ
Citation: Ah. Groll et al., High-performance liquid chromatographic determination of liposomal nystatin in plasma and tissues for pharmacokinetic and tissue distribution studies, J CHROMAT B, 735(1), 1999, pp. 51-62
Update on the treatment of neutropenia in HIV-infected patients - Introduction
Authors: Piscitelli, SC
Citation: Sc. Piscitelli, Update on the treatment of neutropenia in HIV-infected patients - Introduction, AM J HEAL S, 56, 1999, pp. S3-S4
Syndromes of abnormal fat redistribution and metabolic complications in HIV-infected patients
Authors: Struble, K Piscitelli, SC
Citation: K. Struble et Sc. Piscitelli, Syndromes of abnormal fat redistribution and metabolic complications in HIV-infected patients, AM J HEAL S, 56(22), 1999, pp. 2343-2348
Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokinetics
Authors: Groll, AH Gonzalez, CE Giri, N Kligys, K Love, W Peter, J Feuerstein, E Bacher, J Piscitelli, SC Walsh, TJ
Citation: Ah. Groll et al., Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokinetics, J ANTIMICRO, 43(1), 1999, pp. 95-103
Atovaquone suspension in HIV-infected volunteers: Pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study
Authors: Falloon, J Sargent, S Piscitelli, SC Bechtel, C LaFon, SW Sadler, B Walker, RE Kovacs, JA Polis, MA Davey, RT Lane, HC Masur, H
Citation: J. Falloon et al., Atovaquone suspension in HIV-infected volunteers: Pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study, PHARMACOTHE, 19(9), 1999, pp. 1050-1056
Risultati: 1-25 | 26-30